Not Medicare Enrolled

Dr. Gery Florek, MD

Neurology · Tallahassee, FL
Speaking/Promotional
1401 CENTERVILLE RD, Tallahassee, FL 32308
8508789892
In practice since 2006 (19 years)
NPI: 1205919677 verify on NPPES ↗
Moderate
DATA COVERAGE
Data in 2 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Florek from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Florek? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Florek

Dr. Gery Florek is a neurology in Tallahassee, FL, with 19 years in practice.

Between the years covered by Open Payments, Dr. Florek received a total of $78,921 from 48 pharmaceutical and/or device companies across 721 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Florek is Moderate — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice$ $78,921 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$78,921
Total received (2018-2024)
Avg $13,153/year across 6 years
Top 6% in FL for neurology
48
Companies
721
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$67,248 (85.2%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$11,673 (14.8%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$70
2022
$231
2021
$36,602
2020
$27,679
2019
$2,303
2018
$12,036

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Lilly USA, LLC
$22,690
AbbVie Inc.
$18,568
Amgen Inc.
$12,864
Allergan, Inc.
$9,257
Biohaven Pharmaceuticals, Inc.
$4,471
Supernus Pharmaceuticals, Inc.
$4,297
Teva Pharmaceuticals USA, Inc.
$795
Biogen, Inc.
$657
Novartis Pharmaceuticals Corporation
$569
Adamas Pharmaceuticals, Inc.
$524
Lundbeck LLC
$360
UCB, Inc.
$324
Avanir Pharmaceuticals, Inc.
$275
Upsher-Smith Laboratories LLC
$261
Eisai Inc.
$254
ABBVIE INC.
$227
Amneal Pharmaceuticals LLC
$221
JAZZ PHARMACEUTICALS INC.
$166
Novocure Inc.
$157
Egalet US Inc
$149
UPSHER-SMITH LABORATORIES LLC
$143
Allergan Inc.
$135
Alexion Pharmaceuticals, Inc.
$124
EMD Serono, Inc.
$117
E.R. Squibb & Sons, L.L.C.
$112
SK Life Science, Inc.
$110
GENZYME CORPORATION
$104
ASSERTIO THERAPEUTICS, Inc.
$96
Sunovion Pharmaceuticals Inc.
$94
ARBOR PHARMACEUTICALS, INC.
$74
PFIZER INC.
$67
EISAI INC.
$63
Pernix Therapeutics Holdings, Inc.
$59
ACADIA Pharmaceuticals Inc
$57
Promius Pharma LLC
$56
Assertio Therapeutics, Inc.
$56
Neurocrine Biosciences, Inc.
$48
Greenwich Biosciences, Inc.
$47
Arbor Pharmaceuticals, Inc.
$40
NOVARTIS PHARMACEUTICALS CORPORATION
$39
Zyla Life Sciences, Inc.
$39
Impax Laboratories, Inc.
$34
Genentech USA, Inc.
$31
Mitsubishi Tanabe Pharma America, Inc.
$22
Zyla Life Sciences
$20
Celgene Corporation
$20
Bayer HealthCare Pharmaceuticals Inc.
$18
Almatica Pharma LLC
$12
Top 3 companies account for 68.6% of total payments
Associated products mentioned in payments ›
ADUHELM · AIMOVIG · AJOVY · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Aimovig · BOTOX · BOTOX THERAPEUTIC · Betaseron · Briviact · CAMBIA · COPAXONE · Cambia · DUOPA · EMGALITY · Epidiolex · Fycompa · GOCOVRI · Horizant · INGREZZA · KESIMPTA · LEMTRADA · LYRICA · Mavenclad · NAMZARIC · NAPRELAN · NUEDEXTA · NUPLAZID · NURTEC ODT · OCREVUS · ONGENTYS · OXTELLAR XR · Oncology · Optune · QUDEXY XR TOPIRAMATE EXTENDED RELEASE CAPSULES · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · REYVOW · RYTARY · Radicava · SILENOR · SOLIRIS · SPRIX · SUNOSI · TECFIDERA · TOSYMRA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TROKENDI XR · TYSABRI · UBRELVY · VUMERITY · VYEPTI · Vimpat · ZEMBRACE SYMTOUCH · ZEPOSIA · ZOHYDRO ER · ZOMIG · Zembrace · Zembrace SymTouch Sumatriptan Injection · Zipsor
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (85%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in neurology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 6% for neurology in FL.

Looking for a neurology in Tallahassee?
Compare neurologys in the Tallahassee area by procedure volume, costs, and industry payment transparency.
Browse neurologys nearby

Geographic Context

Neurologys within 10 mi
20
Per 100K population
6.8
County median income
$65,074
Nearest hospital
TALLAHASSEE MEMORIAL HEALTHCARE
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment— Not enrolledN/A
Practice Data— No dataN/A
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 2 of 4 available federal datasets, with a Data Coverage level of Moderate. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Florek is a neurology, and high industry engagement (speaking/promotional, top 6%), with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Does Dr. Florek receive payments from pharmaceutical companies?
Yes. Dr. Florek received a total of $78,921 from 48 companies across 721 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently Moderate for Dr. Florek) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →